To further investigate this, we wanted to generate a PtenH/H mouse strain with a concordant PTEN reduction to Pten+/– mice, reasoning that if PTEN dosage alone drives tumor formation, both genotypes should theoretically exhibit similar predisposition to prostate tumorigenesis. The gene discussed is PTEN; the disease is urogenital neoplasm.